Loading...

ShockWave Medical, Inc. Peer Comparison

Metric Value Ranking
Market Cap $12.6 Billion 6/14 SYK
$147.0B
EW
$44.7B
DXCM
$32.8B
PODD
$19.6B
ALGN
$15.3B
SWAV
$12.6B
PEN
$10.2B
MASI
$9.6B
INSP
$5.6B
NARI
$4.7B
TMDX
$2.3B
TNDM
$2.2B
CLPT
$497.4M
OM
$41.9M
Gross Margin 87% 2/14 PODD
100%
SWAV
87%
NARI
87%
INSP
84%
EW
81%
ALGN
69%
PEN
67%
SYK
65%
DXCM
60%
CLPT
60%
TMDX
56%
MASI
52%
TNDM
34%
OM
34%
Profit Margin 25% 2/14 EW
100%
SWAV
25%
PODD
21%
DXCM
14%
ALGN
12%
PEN
10%
INSP
9%
SYK
8%
TMDX
4%
MASI
2%
TNDM
-6%
NARI
-12%
CLPT
-61%
OM
-97%
EBITDA margin 19% 3/14 EW
30%
PODD
24%
SWAV
19%
DXCM
15%
PEN
15%
ALGN
10%
SYK
9%
TMDX
8%
INSP
7%
NARI
-5%
TNDM
-7%
MASI
-12%
CLPT
-64%
OM
-212%
Quarterly Revenue $218.8 Million 9/14 SYK
$6.4B
EW
$1.4B
DXCM
$994.2M
ALGN
$977.9M
MASI
$504.6M
PODD
$372.6M
TNDM
$363.3M
PEN
$301.0M
SWAV
$218.8M
INSP
$203.2M
NARI
$153.4M
TMDX
$108.8M
OM
$28.7M
CLPT
$8.1M
Quarterly Earnings $55.3 Million 6/14 EW
$3.1B
SYK
$546.0M
DXCM
$134.6M
ALGN
$116.0M
PODD
$77.5M
SWAV
$55.3M
PEN
$29.5M
INSP
$18.5M
MASI
$9.8M
TMDX
$4.2M
CLPT
-$5.0M
NARI
-$18.4M
TNDM
-$23.3M
OM
-$27.9M
Quarterly Free Cash Flow $27.5 Million 8/14 ALGN
$326.5M
EW
$319.9M
DXCM
$88.3M
PODD
$76.1M
PEN
$51.0M
INSP
$44.3M
MASI
$33.0M
SWAV
$27.5M
TNDM
$21.5M
NARI
-$995,000
CLPT
-$1.2M
OM
-$20.1M
TMDX
-$41.3M
SYK
-$0
Trailing 4 Quarters Revenue $788.0 Million 9/14 SYK
$22.6B
EW
$5.9B
ALGN
$4.0B
DXCM
$4.0B
MASI
$2.0B
PODD
$1.8B
PEN
$1.2B
TNDM
$973.7M
SWAV
$788.0M
INSP
$755.6M
NARI
$574.5M
TMDX
$401.1M
OM
$114.7M
CLPT
$30.4M
Trailing 4 Quarters Earnings $163.5 Million 6/14 SYK
$6.4B
EW
$1.4B
DXCM
$994.2M
ALGN
$977.9M
MASI
$504.6M
PODD
$372.6M
TNDM
$363.3M
PEN
$301.0M
SWAV
$218.8M
INSP
$203.2M
NARI
$153.4M
TMDX
$108.8M
OM
$28.7M
CLPT
$8.1M
Quarterly Earnings Growth 41% 6/14 EW
698%
INSP
317%
PEN
220%
TMDX
117%
PODD
49%
SWAV
41%
OM
39%
TNDM
29%
DXCM
12%
CLPT
-3%
ALGN
-4%
MASI
-8%
SYK
-52%
NARI
-681%
Annual Earnings Growth -65% 13/14 EW
218%
PODD
215%
TMDX
215%
INSP
174%
DXCM
45%
MASI
36%
CLPT
30%
OM
21%
TNDM
10%
ALGN
-3%
SYK
-7%
PEN
-48%
SWAV
-65%
NARI
-934%
Quarterly Revenue Growth 36% 4/14 TNDM
96%
TMDX
64%
CLPT
41%
SWAV
36%
INSP
33%
NARI
21%
SYK
11%
PEN
11%
MASI
5%
DXCM
2%
ALGN
2%
OM
-6%
EW
-9%
PODD
-14%
Annual Revenue Growth 33% 2/14 TMDX
79%
SWAV
33%
CLPT
29%
TNDM
26%
INSP
25%
NARI
19%
PODD
12%
MASI
11%
DXCM
10%
SYK
10%
PEN
10%
ALGN
0%
EW
-3%
OM
-17%
Cash On Hand $281.7 Million 7/14 EW
$3.7B
SYK
$3.7B
ALGN
$1.0B
PODD
$902.6M
DXCM
$621.2M
TMDX
$330.1M
SWAV
$281.7M
PEN
$280.5M
MASI
$158.5M
INSP
$147.5M
TNDM
$49.0M
NARI
$41.1M
OM
$33.3M
CLPT
$21.6M
Short Term Debt $3.7 Million 9/14 SYK
$12.2B
ALGN
$111.6M
MASI
$61.9M
PODD
$42.0M
EW
$24.2M
DXCM
$22.3M
TNDM
$18.0M
PEN
$14.5M
SWAV
$3.7M
TMDX
$2.5M
OM
$1.7M
NARI
$1.6M
CLPT
$536,000
INSP
$109,000
Long Term Debt $773.1 Million 3/14 DXCM
$2.5B
PODD
$1.4B
SWAV
$773.1M
MASI
$733.2M
EW
$682.5M
TMDX
$508.5M
TNDM
$457.9M
PEN
$212.2M
ALGN
$96.4M
NARI
$31.1M
INSP
$25.2M
CLPT
$3.2M
OM
$3.2M
SYK
$0
PE 76.87 4/14 PEN
296.68
INSP
169.57
MASI
122.12
SWAV
76.87
TMDX
70.04
SYK
49.12
DXCM
48.12
PODD
46.59
ALGN
34.72
EW
10.75
TNDM
-1.00
CLPT
-1.00
NARI
-1.00
OM
-1.00
PS 15.95 2/14 CLPT
16.34
SWAV
15.95
PODD
10.82
PEN
8.81
DXCM
8.29
NARI
8.15
EW
7.61
INSP
7.42
SYK
6.51
TMDX
5.70
MASI
4.71
ALGN
3.87
TNDM
2.26
OM
0.37
PB 16.72 3/14 PODD
17.54
CLPT
17.15
SWAV
16.72
DXCM
16.55
TMDX
10.89
NARI
10.77
PEN
9.28
TNDM
9.27
INSP
8.05
MASI
6.57
EW
4.65
ALGN
3.89
SYK
3.42
OM
0.88
PC 44.62 5/14 NARI
113.76
MASI
60.64
DXCM
52.74
TNDM
44.92
SWAV
44.62
SYK
40.25
INSP
37.99
PEN
36.54
CLPT
23.05
PODD
21.72
ALGN
14.71
EW
12.16
TMDX
6.92
OM
1.26
Liabilities to Equity 1.19 6/14 OM
5.12
TNDM
3.03
TMDX
2.74
DXCM
2.21
PODD
1.71
SWAV
1.19
MASI
1.11
ALGN
0.61
NARI
0.60
CLPT
0.39
EW
0.35
PEN
0.34
INSP
0.14
SYK
0.00
ROA 0.10 4/14 EW
32%
PODD
14%
DXCM
11%
SWAV
10%
SYK
7%
ALGN
7%
INSP
4%
TMDX
4%
MASI
3%
PEN
2%
NARI
-11%
TNDM
-13%
CLPT
-45%
OM
-48%
ROE 0.22 4/14 EW
44%
PODD
38%
DXCM
34%
SWAV
22%
TMDX
16%
ALGN
11%
SYK
7%
MASI
5%
INSP
5%
PEN
3%
NARI
-18%
TNDM
-53%
CLPT
-63%
OM
-295%
Current Ratio 1.84 8/14 INSP
7.99
PEN
3.95
EW
3.86
CLPT
3.59
NARI
2.66
ALGN
2.63
MASI
1.90
SWAV
1.84
PODD
1.59
DXCM
1.45
TMDX
1.36
TNDM
1.33
OM
1.20
SYK
-1.00
Quick Ratio 1.15 4/14 PEN
296.68
INSP
169.57
MASI
122.12
SWAV
76.87
TMDX
70.04
SYK
49.12
DXCM
48.12
PODD
46.59
ALGN
34.72
EW
10.75
TNDM
-1.00
CLPT
-1.00
NARI
-1.00
OM
-1.00
Long Term Debt to Equity 1.03 5/14 TMDX}
2.42
TNDM}
1.93
DXCM}
1.27
PODD}
1.21
SWAV}
1.03
MASI}
0.50
PEN}
0.19
CLPT}
0.11
EW}
0.07
NARI}
0.07
OM}
0.07
INSP}
0.04
ALGN}
0.02
SYK}
0.00
Debt to Equity 1.03 5/14 TMDX
2.42
TNDM
2.00
DXCM
1.28
PODD
1.25
SWAV
1.03
MASI
0.50
SYK
0.28
PEN
0.21
CLPT
0.13
OM
0.10
NARI
0.08
EW
0.07
INSP
0.04
ALGN
0.02
Burn Rate -11.98 10/14 TMDX
19.69
MASI
4.53
CLPT
4.12
NARI
2.06
SYK
1.46
OM
1.17
TNDM
1.06
EW
-1.21
INSP
-8.45
SWAV
-11.98
ALGN
-12.37
PEN
-16.10
DXCM
-21.72
PODD
-70.80
Cash to Cap 0.02 9/14 OM
0.79
TMDX
0.14
EW
0.08
ALGN
0.07
PODD
0.05
CLPT
0.04
PEN
0.03
INSP
0.03
SWAV
0.02
TNDM
0.02
DXCM
0.02
SYK
0.02
MASI
0.02
NARI
0.01
CCR 0.50 8/14 MASI
3.37
ALGN
2.82
INSP
2.39
PEN
1.73
PODD
0.98
OM
0.72
DXCM
0.66
SWAV
0.50
CLPT
0.24
EW
0.10
NARI
0.05
TNDM
-0.93
TMDX
-9.81
SYK
EV to EBITDA 308.03 2/14 INSP}
382.86
SWAV}
308.03
TMDX}
289.17
SYK}
267.72
PEN}
230.35
PODD}
228.20
DXCM}
228.10
ALGN}
150.23
EW}
103.65
OM}
-0.22
CLPT}
-92.71
TNDM}
-100.78
MASI}
-170.90
NARI}
-647.99
EV to Revenue 16.58 1/14 SWAV
16.58
CLPT
15.76
PODD
11.09
DXCM
8.77
PEN
8.76
NARI
8.13
INSP
7.25
EW
7.11
SYK
6.88
TMDX
6.14
MASI
4.99
ALGN
3.63
TNDM
2.70
OM
0.12